Copyright
©The Author(s) 2025.
World J Transplant. Mar 18, 2025; 15(1): 99004
Published online Mar 18, 2025. doi: 10.5500/wjt.v15.i1.99004
Published online Mar 18, 2025. doi: 10.5500/wjt.v15.i1.99004
Table 3 Characteristics of hepatocellular carcinoma recurrence after liver transplantation, n (%)
| Variable | Overall (n = 10) |
| Time to recurrence (years) | 2.9 ± 0.75 |
| < 2 | 4 (40) |
| > 2 | 6 (60) |
| Location | |
| Hepatic | 1 (10) |
| Extrahepatic | 9 (90) |
| Alpha-fetoprotein at time of recurrence (ng/mL) | 4700 ± 9394 |
| Treatment of recurrence | |
| Yes | 6 (60) |
| No | 4 (40) |
| Type of treatment | |
| Systemic therapy | 1 (10) |
| Surgery | 0 (0) |
| Radiotherapy | 1 (10) |
| Combined | 2 (20) |
| Other | 2 (20) |
- Citation: Garas MG, Calzadilla-Bertot L, Smith BW, Delriviere L, Jaques B, Mou L, Adams LA, MacQuillan GC, Garas G, Jeffrey GP, Wallace MC. Hepatocellular carcinoma recurrence after liver transplant: An Australian single-centre study. World J Transplant 2025; 15(1): 99004
- URL: https://www.wjgnet.com/2220-3230/full/v15/i1/99004.htm
- DOI: https://dx.doi.org/10.5500/wjt.v15.i1.99004